Allogene Therapeutics Inc (ALLO)
Stock-Based Compensation
$12.44M
Quarterly · Period ending: · USD
ALLO Stock-Based Compensation
Latest reported$12.44Mperiod ending
Latest reported$12.44Mperiod ending
ALLO Quarterly Stock-Based Comp ($0.00 → $12.44M)
Quarterly stock-based compensation
High-resolution chart · PNG
ALLO stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 12,440,000 | |
| 8,270,000 | |
| 8,130,000 | |
| 8,652,000 | |
| 8,685,000 | |
| 12,175,000 | |
| 12,873,000 | |
| 13,387,000 | |
| 13,559,000 | |
| 11,924,000 | |
| 15,233,000 | |
| 15,354,000 | |
| 16,594,000 | |
| 18,770,000 | |
| 17,246,000 | |
| 21,148,000 | |
| 22,891,000 | |
| 22,315,000 | |
| 22,036,000 | |
| 20,856,000 | |
| 21,134,000 | |
| 16,792,000 | |
| 16,453,000 | |
| 17,823,000 | |
| 16,770,000 | |
| 14,215,000 | |
| 13,874,000 | |
| 12,835,000 | |
| 11,487,000 | |
| 7,867,000 | |
| 5,871,000 | |
| 4,639,000 | |
| 8,056,000 | |
| 0 | |
| 0 |